Skip to content

Aurinia Pharmaceuticals AUPH Other current assets

Other current assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.6B-16.9%
Rogers Corporation logo
Rogers CorporationROG
Arrowhead Research logo
Arrowhead ResearchARWR
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.3B+78.5%
Enterprise value$2.34B+78.3%
P/E7.7×-24.6×
P/S7.7×+2.5×

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's other current assets?
Aurinia Pharmaceuticals (AUPH) reported other current assets of $1.76M in Q1 2026.
How has Aurinia Pharmaceuticals's other current assets changed year-over-year?
Aurinia Pharmaceuticals's other current assets increased by 125.0% year-over-year, from $781K to $1.76M.
What is the long-term trend for Aurinia Pharmaceuticals's other current assets?
Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's other current assets has grown at a 1.2% compound annual growth rate (CAGR), from $1.02M to $1.08M.